Posterior Uveitis: Clinical Trials

3 trials for Posterior Uveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1
Phase 31Completed 1

Follow Posterior Uveitis: new trials by email Literature Review of Posterior Uveitis trials Research Report on Posterior Uveitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis
Phase 1 / Phase 2CompletedClearside Biomedical, Inc.112013-02-012021-02-21
Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
AEB071 - Uveitis, Posterior Uveitis
Phase 2CompletedNovartis132008-07-012020-12-22
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Dexamethasone, dexamethasone, Sham injection - Intermediate Uveitis, Posterior Uveitis
Phase 2 / Phase 3CompletedAllergan2292006-05-012011-04-14

Narrower conditions

Uveitis, Posterior (3)  ·  Panuveitis (2)  ·  Uveitis (2)  ·  Uveitis, Intermediate (2)  ·  Choroidal Effusions (1)  ·  Giant Cell Arteritis (1)  ·  Inflammation (1)  ·  Macular Edema (1)  ·  Ophthalmia, Sympathetic (1)

Broader conditions

Eye Diseases (3)  ·  Uveal Diseases (3)  ·  Arteritis (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Choroid Diseases (1)  ·  Eye Abnormalities (1)  ·  Immune System Diseases (1)  ·  Macular Degeneration (1)  ·  Nervous System Diseases (1)  ·  Panuveitis (1)

Interventions

Adrenal Cortex Hormones (1)  ·  Dexamethasone (1)  ·  Triamcinolone (1)  ·  Triamcinolone Acetonide (1)  ·  salicylhydroxamic acid (1)  ·  sotrastaurin (1)

Sponsors

Allergan (1)  ·  Clearside Biomedical, Inc. (1)  ·  Novartis (1)

Countries

United States (3)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)  ·  Poland (1)  ·  Portugal (1)  ·  South Africa (1)  ·  South Korea (1)

Top investigators

Thomas Ciulla, MD (1)

Results publications

PMID 21220619, PMID 23411886, PMID 23761087, PMID 27980877